ARMS2 and age-related macular degeneration: As it was demonstrated by The EYE-RISK Consortium [33], the complement pathway and ARMS2 alone confer at least 90% of the genetic burden for late AMD, but genes from other pathways also account for genetic burden, highlighting the polygenic nature of AMD, and explaining the high prevalence of genetic susceptibility for AMD.